CV Advisors’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-21,842
Closed -$237K 38
2025
Q1
$237K Hold
21,842
0.08% 33
2024
Q4
$208K Hold
21,842
0.07% 30
2024
Q3
$245K Hold
21,842
0.12% 19
2024
Q2
$218K Hold
21,842
0.11% 20
2024
Q1
$251K Hold
21,842
0.14% 20
2023
Q4
$159K Hold
21,842
0.11% 21
2023
Q3
$199K Hold
21,842
0.15% 21
2023
Q2
$266K Hold
21,842
0.2% 19
2023
Q1
$271K Hold
21,842
0.24% 18
2022
Q4
$420K Hold
21,842
0.4% 16
2022
Q3
$410K Hold
21,842
0.4% 16
2022
Q2
$394K Hold
21,842
0.37% 17
2022
Q1
$350K Buy
+21,842
New +$393K 0.25% 23

Other funds holding AHCO

CV Advisors's AHCO Position: Q2 2025 in Review

CV Advisors sold out of AdaptHealth (AHCO) in Q2 2025, closing a stake of 21,842 shares — an estimated $237K sold.

CV Advisors first reported a position in AHCO in Q1 2022 and held it in 13 quarters. The position peaked at $420K in Q4 2022. 218 funds tracked by Wall St. Rank hold AHCO as of Q2 2025.

  • CV Advisors reported no remaining AdaptHealth position as of Q2 2025 after selling out during the quarter.
  • CV Advisors sold 21,842 AdaptHealth shares in Q2 2025, an estimated $237K.
  • CV Advisors first reported a position in AdaptHealth in Q1 2022 and held it in 13 quarters.
  • CV Advisors's AdaptHealth position peaked at $420K in Q4 2022.
  • 218 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2025.

Based on CV Advisors's 13F filing for Q2 2025, filed 25 Jul 2025.